These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Progressive multifocal leukoencephalopathy in patients with AIDS: is there a change in patients treated with highly active antiretroviral therapies?]. Montes Santiago J; Pérez Fernández E; González Vázquez L; Morano Amado L; Fernández Martín J; Asorey Carballeira A; Pérez Alvarez R An Med Interna; 2002 May; 19(5):230-3. PubMed ID: 12107996 [TBL] [Abstract][Full Text] [Related]
28. New features of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy and natalizumab. Lima MA; Koralnik IJ J Neurovirol; 2005; 11 Suppl 3():52-7. PubMed ID: 16540456 [TBL] [Abstract][Full Text] [Related]
29. Progressive multifocal leukoencephalopathy: new concepts. Lima MA Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508 [TBL] [Abstract][Full Text] [Related]
30. Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis. Sahraian MA; Radue EW; Eshaghi A; Besliu S; Minagar A Eur J Neurol; 2012 Aug; 19(8):1060-9. PubMed ID: 22136455 [TBL] [Abstract][Full Text] [Related]
31. Detection of JC virus in two African cases of progressive multifocal leukoencephalopathy including identification of JCV type 3 in a Gambian AIDS patient. Stoner GL; Agostini HT; Ryschkewitsch CF; Mazló M; Gullotta F; Wamukota W; Lucas S J Med Microbiol; 1998 Aug; 47(8):733-42. PubMed ID: 9877195 [TBL] [Abstract][Full Text] [Related]
32. Opportunistic infections of the CNS in patients with AIDS: diagnosis and management. Collazos J CNS Drugs; 2003; 17(12):869-87. PubMed ID: 12962527 [TBL] [Abstract][Full Text] [Related]
33. [Focal presentation of progressive multifocal leukoencephalopathy: first manifestation of human immunodeficiency virus infection]. Martínez L; Cuesta J; Santos S; Tejero C Neurologia; 2008 Oct; 23(8):532-5. PubMed ID: 18392989 [TBL] [Abstract][Full Text] [Related]
35. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. Boren EJ; Cheema GS; Naguwa SM; Ansari AA; Gershwin ME J Autoimmun; 2008; 30(1-2):90-8. PubMed ID: 18191544 [TBL] [Abstract][Full Text] [Related]
36. The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy. Welch K; Morse A; AIDS Patient Care STDS; 2002 Feb; 16(2):75-81. PubMed ID: 11874639 [TBL] [Abstract][Full Text] [Related]
37. [Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: the clinical, neuroimaging, virological and evolutive characteristics in 35 patients]. Asensi V; Cartón JA; Maradona JA; Oña M; Melón S; Martín-Roces ER; Asensi JM; Arribas JM Med Clin (Barc); 1999 Sep; 113(6):210-4. PubMed ID: 10472609 [TBL] [Abstract][Full Text] [Related]
39. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217 [TBL] [Abstract][Full Text] [Related]
40. The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. De Luca A; Giancola ML; Ammassari A; Grisetti S; Paglia MG; Gentile M; Cingolani A; Murri R; Liuzzi G; Monforte AD; Antinori A J Infect Dis; 2000 Oct; 182(4):1077-83. PubMed ID: 10979902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]